Exceptional Ventures is an early-stage Venture Capital firm based in London that invests in high-impact businesses focused on helping people live happier, healthier, and longer lives, while championing a sustainable planet.
Ada Ventures leads the seed round to support the development of AI voice agents for general practices.
"For most patients, the GP reception desk is the front door to the entire NHS, and it’s under more strain than any other part of the system. InTouchNow was built to handle the repetitive, time-consuming calls so reception teams can focus on the patients who really need a person. Ada’s backing is a strong vote of confidence in British healthtech, and lets InTouchNow bring safe, ethical, and genuinely useful AI to many more NHS practices across the UK."
The pre-seed round was co-led by Kadmos Capital and Exceptional Ventures and will support the transition of designed drug combinations into wet-lab validation.
"Cancer is not one disease driven by one target, but we still develop drugs as if it were. Combinations are how we beat it – and with more than 900 billion of them possible, no lab on earth can test its way to the right ones. That is the problem we built Big Picture Bio to solve: model the disease as the dynamic system it actually is, then design against it – combinations chosen because they are most likely to work in patients, not because they were the ones we could get to. This funding takes our first designed combinations out of the model and into the lab."
Octopus Ventures and CommerzVentures joined the round to support international expansion and product development.
"What we’re building is the agent layer that financial services need to run their customer operations autonomously. It has to work the way they do, connect to the systems they have already built, and handle the long-running work that has stayed manual until now"
AlbionVC led the Series A round for the healthcare-as-a-service provider, with backing from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI.